Zivo Bioscience Inc. (ZIVO) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zivo Bioscience Inc. (ZIVO:NASDAQ), powered by AI.

Current Price
$2.07
P/E Ratio
-0.5
Market Cap
7M
Sector
Healthcare
What is the Zivo Bioscience Inc. stock price forecast?

Zivo Bioscience Inc. is currently trading at $2.07. View real-time AI analysis on Alpha Lenz.

What is Zivo Bioscience Inc. insider trading activity?

View the latest insider trading data for Zivo Bioscience Inc. on Alpha Lenz.

What is Zivo Bioscience Inc.'s P/E ratio?

Zivo Bioscience Inc.'s P/E ratio is -0.5.

Zivo Bioscience Inc.

NASDAQ · ZIVO
$2.07
Ask about Zivo Bioscience Inc.'s future dividend policy...
Alpha Chat Insight

Zivo Bioscience Inc. trades at a P/E of -0.5 (undervalued) with strong ROE of 983.9%.

Ask for details

Company Overview

Zivo Bioscience Inc. is a research and development company specializing in biotechnology, with a focus on leveraging proprietary algal and bacterial strains to create innovative nutritional compounds and bioactive molecules. The company's core operations center around the study, development, and commercialization of naturally derived ingredients targeting both human and animal health. Zivo Bioscience actively develops and licenses intellectual property, including unique algae cultures, extracts, and patented or patent-pending product concepts. Its primary fields of application include human dietary supplements, nutraceuticals, food ingredients, and animal feed additives, with projects addressing areas such as poultry gut health, bovine mastitis, canine joint health, and human immune modulation. Operating across both the biotech and agtech sectors, Zivo’s business model is heavily based on licensing its technology and selling specialized bioactive compounds to manufacturers in the nutrition, supplement, and medical food industries, emphasizing the growing market demand for natural, functional ingredients.

CEOMr. John Bernard Payne
SectorHealthcare
IndustryBiotechnology
Employees7

Company Statistics

FY 2024

Profile

$6.56MMarket Cap
$157.22KRevenue
0.00Shares Out
7Employees

Margins

31.14%Gross
-8498.85%EBITDA
-8498.85%Operating
-8513.44%Pre-Tax
-8513.44%Net

Valuation

-0.49P/E
-12.73P/B
41.70EV/Sales
-0.39EV/EBITDA
-1.52P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1217.45%ROA
983.91%ROE
-1215.36%ROIC

Financial Health

$1.54MCash & Cash Equivalents
$615.58KNet Debt
-419.12%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Zivo Bioscience Inc. (ticker: ZIVO) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 7 employees. Market cap is $7M.

The current price is $2.07 with a P/E ratio of -0.49x and P/B of -12.73x.

ROE is 983.91% and operating margin is -8498.85%. Annual revenue is $157,220.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Zivo Bioscience Inc. (Healthcare) Stock Forecast & Analysis $2.07 | Alpha Lenz